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 A B S T R A C T 
Background: Cervical and breast cancer are the two top leading cases of female cancer 
worldwide. Both cases share some similar clinical manifestations as specific symptoms 
of cancer. Physical wellbeing often decreased as frequent symptoms appear. This study 
aimed to compare and analyze the physical wellbeing among cervical cancer and breast 
cancer survivors (CCS and BCS). 
Methods: This cross-sectional study involved 47 CCS and 58 BCS in the district of 
Rangkah, Gading, and Pacarkeling, Surabaya, Indonesia. Instrument of Quality of Life – 
Cancer Survivors (QOL-CS) was used for data collection. Independent sample T test and 
Mann-Whitney U test were used in data analysis (α< .05).   
Results: More severe fatigue, appetite changes, pain, sleep disturbance, constipation, 
nausea-vomiting, and menstrual changes were found in CCS. More poor perceived 
health status and optimal physical wellbeing were found in BCS. Overall, most sufficient 
physical wellbeing was found in both groups. There were significant differences of 
fatigue, pain, sleep disturbance, appetite changes, constipation, health status (p<.001 
for each), nausea-vomiting (p= .004), and menstrual changes (p= .001) were found 
between groups. Overall, physical wellbeing was significantly different between groups 
(p< .001). Sleep disturbance (84.7% of influence) and appetite changes (75.7% of 
influence) were the best predictors for determining physical wellbeing in CCS and BCS 
respectively.  
Conclusion: More severe cancer symptoms were found in CCS, but more poor 
perceived health status was found in BCS. There was a significant difference of physical 
wellbeing found between CCS and BCS.   
 
 
 
INTRODUCTION 
 
Cancer is the growth of new cells that form 
abnormal tissue and characterized by uncontrolled 
function (1). It can be estimated that the incidence of 
cancer in Indonesia is 0.1% of the population, and more 
than 50% of cancer patients firstly come to seek for 
medication in an advanced stage. According to World 
Health Organization (WHO) statistics, cancer is the 
highest cause of death in the world; up to 7.6 million 
deaths (13% of all deaths) in 2008. In the same year, 
Indonesia's death rate from cancer was 245 per-100,000 
inhabitants (men > women) in which lung cancer being 
the most frequent killer, followed by breast and colon 
cancer. In 2014, breast cancer occupies the first position 
of leading cause of death, followed by cervical cancer 
with the number of 20.928 cases in Indonesian women 
(2). In the period of six years we can see that more 
women suffered from cancer. Cervical and breast  
 
 
cancer have been the two top leading cases of female 
cancer in Indonesia for several years until now.  
The pain/suffering experienced by cancer patients is 
total pain/suffering which consists of physical, 
psychological, social, and spiritual problems (3). All of 
these problems are rooted from the level of cancer 
symptoms or clinical manifestation. In the case of 
advanced cancer (stages 3 and 4), this total 
pain/suffering will further adversely affect the physical 
wellbeing and health status along with the disease 
progression. Physical wellbeing is a state of the ability to 
be fully engaged on a regular basis including its 
development (4). In the case of cancer, there are eight 
indicators of physical wellbeing which are being a part 
of quality of life domains in cancer survivors, namely: 
fatigue, appetite changes, pain, sleep disturbance, 
constipation, nausea-vomiting, menstrual changes, and 
health status (perceived) (5). Patients with multiple and 
severe cancer symptoms had worse performance status, 
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role functioning; physical, emotional, cognitive, social, 
and overall health-related quality of life (HRQOL) (6). 
Therefore, physical wellbeing often decreased as 
frequent cancer symptoms appear. This study aimed to 
compare and analyze the physical wellbeing among 
cervical cancer survivors (CCS) and breast cancer 
survivors (BCS). By knowing this study results, physicians 
and nurses in the field could stress their interventions 
towards specific cancer symptoms which significantly 
impact the physical wellbeing of CCS and BCS as this 
variable being one of the domain of HRQOL. 
 
METHODS 
 
This cross-sectional study involved 47 CCS and 58 
BCS in the district of Rangkah, Gading, and Pacarkeling, 
Surabaya, Indonesia. Inclusion criteria were being an 
adult (> 18 years old), with cancer diagnosis that has 
been confirmed, and regularly home-visited by a 
palliative volunteer under the supervision of Rangkah 
Public Health Center, Surabaya. Exclusion criteria were 
rejection on filling out the consent form, very poor 
condition, and consciousness loss or disorientation. 
Total sampling was applied and sample size of 105 was 
obtained. Instrument of QOL-CS developed by Ferrel, et 
al. (1995) was used in data collection process (5). Data 
were collected since February until March, 2018. 
Independent sample T test and Mann-Whitney U test 
were used in data analysis (α<.05). Ethical clearance was 
issued by Faculty of Nursing, Universitas Airlangga, 
Surabaya, Indonesia, with certificate number of 681-
KEPK. 
 
RESULTS 
 
Most respondents were Javanese, Islam, married, 
housewife, with Gross Domestic Product (GDP) less than 
the minimum wage of Surabaya in 2018 (IDR 
3,300,000.00). Educational background, occupational 
status, and GDP were better in the group of BCS. CCS 
were mostly aged 51-60 years old with tendency to 
elderly, but BCS were mostly aged 41-60 years old with 
tendency to younger age. These results indicate that the 
majority of female cancers suffered by late adult 
women were occured among lower-middle 
socioeconomic status. CCS who was married mostly had 
no child, but most BCS live with their spouse and 
children. More single women were found to have breast 
cancer in this study. Table 1 shows the demography 
characteristic of study respondents in details.  
In this study context, more cases of breast cancer 
were found compared to cervical cancer cases (more 
than 50%). This result further confirmed that breast 
cancer was still being the top leading cases of female 
cancer in Indonesia since 2014. Until now, breast and 
cervical cancer are still being the two top leading cases 
of female cancer in Indonesia. 
The majority of respondents in both groups were 
diagnosed before 2014 (more than four years before 
this study was conducted). This indicates that the 
survival rate of breast and cervical cancer is particularly 
long, which makes both types of cancer a chronic 
disease with high burden that requires long-term and 
supportive/palliative care. Most BCS undertook surgery 
only, both for curative and palliative purposes. In the 
other hand, most CCS undertook a more complex 
regiment, which is a modification of surgery and chemo-
radiotherapy. There were 1.9% of total respondents 
prefer not to undergo any therapy. Regardless of 
minimum information, lack of knowledge, financial 
problems, or personal beliefs/preference, these 1.9% 
respondents expressed good condition despite of not 
getting any therapy. 
Data of fatigue, pain, sleep disturbance, and overall 
physical wellbeing were normally distributed (p = .231, p 
= 157, p = .063, and p = .484 respectively), therefore the 
independent sample T test was used for analyzing the 
data. In the other hand, data of appetite changes, 
constipation, nausea-vomiting, menstrual changes, and 
health status were not normally distributed (p > α), 
therefore Mann-Whitney U test was used for analyzing 
the data. There were significant differences of fatigue, 
pain, sleep disturbance, appetite changes, constipation, 
health status (p < .001 for each), nausea-vomiting (p =. 
004), and menstrual changes (p = .001) found between 
CCS and BCS. Overall, physical wellbeing was 
significantly different between CCS and BCS (p<.001). 
Table 3 explains the differences of every aspect of 
physical wellbeing in both groups.  
We found more severe fatigue, appetite changes, 
pain, sleep disturbance, constipation, nausea-vomiting, 
and menstrual changes in CCS. Surprisingly, they 
expressed better health status than BCS. Even so, 
physical wellbeing was better in BCS. This may be 
influence by various factors involving disease 
mechanism, host response towards tumor/cancer, and 
side effect of anti-cancer therapy. Physical wellbeing as 
defined by Ferrel et al. (1995) is the summary of fatigue, 
appetite changes, pain, sleep disturbance, constipation, 
nausea-vomiting, menstrual changes, and health status 
(perceived) (5). We tried to determine which one of all 
these aspects being the best predictor or major 
determinant of physical wellbeing in CCS and BCS. 
Simple linear regression test was used for analyzing the 
data. 
Sleep disturbance is the best predictor of physical 
wellbeing in CCS followed by pain, nausea-vomiting, 
appetite changes, fatigue, constipation, menstrual 
changes, and health status. Sleep necessity needs to be 
addressed optimally in CCS together with good pain 
management because pain is highly potential to be the 
cause of sleep problems.  
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Table 1. Demography characteristics 
Characteristics 
Cervical cancer  
(n=47) 
Breast cancer 
(n=58)  
Frequency % Frequency % 
1.    Age (years old) 
a. < 21  
 
0 
 
0 
 
1 
 
1.7 
b. 21-30  0 0 5 8.6 
c. 31-40  
d. 41-50  
e. 51-60  
f. 61-70 
g. > 70  
5 
11 
17 
13 
1 
10.6 
23.4 
36.1 
27.6 
2.1 
10 
15 
15 
8 
4 
17.2 
25.8 
25.8 
13.7 
6.9 
2.    Religion 
a. Catholic 
b. Christian 
c. Islam 
 
0 
7 
40 
 
0 
14.8 
85.1 
 
1 
11 
46 
 
1.7 
18.9 
79.3 
3.    Ethnic 
a. Javanese 
b. Maduranese 
c. Chinese 
 
40 
6 
1 
 
85.1 
12.7 
2.1 
 
57 
0 
1 
 
98.2 
0 
1.7 
4.   Educational background 
a. Primary school 
 
15 
 
31.9 
 
11 
 
18.9 
b. Secondary school 
c. High school 
d. Diploma / Bachelor degree 
e. Uneducated  
14 
13 
2 
3 
29.7 
27.6 
4.2 
6.3 
5 
26 
15 
1 
8.6 
44.8 
25.8 
1.7 
5.    Marital status 
a. Single 
b. Married 
c. Widow 
d. Divorce 
 
3 
39 
4 
1 
 
6.3 
82.9 
8.5 
2.1 
 
8 
36 
14 
0 
 
13.7 
62.0 
24.1 
0 
6.   Living at home with 
a. Spouse 
b. Children 
c. Alone 
d. Parents 
e. Sibling 
7.    Occupational status 
a. Full-timer 
b. Part-timer 
c. Retired  
d. Housewife 
e. Seeking for a job 
f. Unemployed  
 
39 
17 
3 
0 
0 
 
2 
3 
0 
40 
0 
2 
 
82.9 
36.1 
6.3 
0 
0 
 
4.2 
6.3 
0 
85.1 
0 
4.2 
 
30 
35 
2 
11 
2 
 
11 
2 
4 
37 
1 
3 
 
51.7 
60.3 
3.4 
18.9 
3.4 
 
18.9 
3.4 
6.9 
63.7 
1.7 
5.1 
8.    GDP per month  
a. Less than minimum wage 
b. Minimum wage - IDR 5 million 
c. More than IDR 5 million 
d. No income  
 
34 
8 
3 
2 
 
72.3 
17.0 
6.3 
4.2 
 
34 
14 
6 
3 
 
58.6 
24.1 
10.3 
5.1 
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Appetite changes is being the best predictor for 
determining physical wellbeing in BCS, followed by 
fatigue, nausea-vomiting, constipation, pain, sleep 
disturbance, menstrual changes, and health status. 
Appetite changes could cause nutritional problem, 
therefore clinicians should give more attention to 
appetite changes in BCS.  
 
DISCUSSION 
 
Results showed that there were significant 
differences of fatigue, pain, sleep disturbance, appetite 
changes, constipation, health status (p < .001 for each), 
nausea-vomiting (p = .004), and menstrual changes (p = 
.001) found between CCS and BCS. Overall, physical 
wellbeing was significantly different between CCS and 
BCS (p< .001). Sleep disturbance and appetite changes 
are the best predictor of physical wellbeing in CCS and 
BCS respectively (p < .001 for each).  
Cancer-related fatigue (CRF) is a highly prevalent and 
debilitating symptom experienced by most cancer 
patients during, and often for considerable periods 
after, treatment. The negative impact of CRF could be 
experienced even before the formal diagnosis of cancer 
was established, and continually existed in the process 
of therapy (7). This CRF was found to be significantly 
different in CCS and BCS. Table 3 showed that most 
respondents of both cases experienced moderate 
fatigue, but more severe fatigue was found in CCS. This 
possibly caused by the complexity of therapeutic 
regiment followed by CCS as shown in Table 2: mostly 
surgery + chemotherapy + radiotherapy (36.17%), 
compared to most surgery only in BCS (44.83%). 
 
Table 2: Primary data 
 
Characteristics 
Cervical cancer (n=47) Breast cancer (n=58)  
Frequency % Frequency % 
1.    Firstly diagnosed 
a. 2018 
b. 2017 
c. 2016 
d. 2015 
e. 2014 
f. < 2014 
 
0 
7 
12 
5 
5 
18 
 
0 
14.8 
25.5 
8.6 
8.6 
38.3 
 
4 
16 
7 
10 
3 
18 
 
6.9 
27.5 
12.0 
17.2 
5.1 
31.0 
2.    Type of therapy 
a. Surgery  
b. Chemotherapy 
c. Surgery + chemotherapy 
d. Surgery + radiotherapy 
e. Chemotherapy + radiotherapy 
f. Surgery + chemotherapy + radiotherapy 
g. Surgery + chemotherapy + radiotherapy + analgesic  
h. Surgery + chemotherapy + radiotherapy + medicine 
i. Surgery + chemotherapy + oral medicine  
j. Oral medicine (various types) 
k. Untreated 
 
5 
13 
2 
0 
7 
17 
1 
1 
0 
0 
1 
 
8.6 
27.6 
4.2 
0 
14.8 
36.1 
2.1 
2.1 
0 
0 
2.1 
 
26 
8 
11 
1 
1 
5 
0 
0 
1 
4 
1 
 
44.8 
13.7 
18.9 
1.7 
1.7 
8.6 
0 
0 
1.7 
6.9 
1.7 
 
 
Table 3: Physical wellbeing in CCS and BCS 
 
Characteristics 
Cervical cancer (n=47) Breast cancer (n=58)  
Frequency % Frequency % 
1.    Fatigue 
       a.   Severe  
 
19 
 
40.4 
 
10 
 
17.2 
       b.   Moderate 
       c.   Mild  
23 
5 
48.9 
10.6 
21 
7 
36.2 
12.0 
2.    Appetite changes 
       a.   Severe 
       b.   Moderate 
       c.   Mild 
 
18 
17 
12 
 
38.3 
36.1 
25.5 
 
6 
11 
41 
 
10.3 
18.9 
70.6 
3.    Pain 
       a.   Severe 
 
14 
 
29.7 
 
5 
 
8.6 
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       b.   Moderate 
       c.   Mild 
26 
7 
55.3 
14.8 
15 
38 
25.8 
65.5 
4.   Sleep disturbance 
       a.   Severe 
       b.   Moderate 
       c.   Mild 
 
16 
19 
12 
 
34.0 
40.4 
25.5 
 
6 
13 
39 
 
10.3 
22.4 
67.2 
5.    Constipation 
       a.   Severe 
       b.   Moderate 
       c.   Mild 
 
3 
19 
25 
 
6.3 
40.4 
53.1 
 
2 
6 
50 
 
3.4 
10.3 
86.2 
6.   Nausea-vomiting  
       a.   Severe 
       b.   Moderate 
       c.   Mild  
7.    Menstrual changes  
       a.   Severe 
       b.   Moderate 
       c.   Mild 
 
10 
14 
23 
 
14 
24 
9 
 
21.2 
29.7 
48.9 
 
29.7 
51.0 
19.1 
 
3 
6 
49 
 
11 
16 
31 
 
5.1 
10.3 
84.4 
 
18.9 
27.5 
53.4 
8.    Health status   
       a.   Severe 
       b.   Moderate 
       c.   Mild 
 
22 
21 
4 
 
46.8 
44.6 
8.5 
 
45 
10 
3 
 
77.5 
17.2 
5.1 
9.    Physical wellbeing (overall) 
       a.   Poor 
       b.   Sufficient 
       c.   Good 
 
8 
30 
9 
 
17.0 
63.8 
19.1 
 
3 
21 
34 
 
5.1 
36.2 
58.6 
*Category was made to ease the data presentation only, and not for statistical analysis purposes 
 
Table 4a: Predictors of physical wellbeing in CCS  
 
No. Determinant R Square % OF Influence Sig. 
1 Fatigue .611 61.1 .000 
2 Appetite changes .659 65.9 .000 
3 Pain .751 75.1 .000 
4 Sleep disturbance .847 84.7 .000 
5 Constipation .562 56.2 .000 
6 Nausea-vomiting .734 73.4 .000 
7 Menstrual changes .118 11.8 .018 
8 Health status .001 - .833 
9 Fatigue, pain, and sleep disturbance (normally distributed 
data) 
.880 88.0 .000 
10 Appetite changes, constipation, nausea-vomiting, menstrual 
changes, and health status (abnormally distributed data) 
.966 96.6 .000 
 
Table 4b: Predictors of physical wellbeing in BCS 
 
No. Determinant R Square % OF Influence Sig. 
1 Fatigue .599 59.9 .000 
2 Appetite changes .757 75.7 .000 
3 Pain .480 48.0 .000 
4 Sleep disturbance .348 34.8 .000 
5 Constipation .531 53.1 .000 
6 Nausea-vomiting .551 55.1 .000 
7 Menstrual changes .252 25.2 .000 
8 Health status .099 9.9 .016 
9 Fatigue, pain, and sleep disturbance (normally distributed 
data) 
.809 80.9 .000 
10 Appetite changes, constipation, nausea-vomiting, 
menstrual changes, and health status (abnormally 
distributed data) 
.904 90.4 .000 
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Disease stressor and cancer therapy cause the 
decrease of four main body functions (cognitive, 
nutrition, muscular tone, and sleep quality) influencing 
the adjustment to sick condition, in which the changes 
of biological, psychological, and functional aspects 
induce CRF in cancer survivors (8). This statement was 
confirmed by a study of Bower, et al. (2011) which 
found that women treated with chemotherapy 
endorsed higher levels of all symptoms and also had 
higher plasma levels of soluble Tumor Necrosis Factor 
Receptor type II (sTNF-RII) than women who did not 
receive chemotherapy (all p<.05). Fatigue was positively 
associated with sTNF-RII, particularly in the 
chemotherapy-treated group (p<.05) (9). 
Pain in cancer patients remains common and is often 
associated with insufficient prescription of targeted 
analgesia in which the proportion of pain caused by 
cancer treatment was higher in neuropathic pain 
compared to all types of cancer pain (10). Pain was 
found to be significantly different in CCS and BCS. Table 
3 showed that most CCS experienced moderate pain 
(55.32%), compared to mostly mild pain in BCS 
(65.52%). This possibly happened due to insufficient 
analgesia or the complexity of cancer treatment 
followed by CCS as shown in Table 2. Other than that, 
advanced cervical cancer could cause symptoms 
including abnormal vaginal bleeding, also after coitus, 
discharge, pelvic pain, and dyspareunia (pain during 
intercourse) (11).  
Sleep disturbance is one of the risk factor of cancer 
because melatonin (pineal hormone) is involved in the 
inhibition of cancer development and growth, and the 
enhancement of immune function. Individuals with 
sleep disturbances are not only immuno- suppressed, 
but they are also at an increased risk of developing a 
number of different types of cancer (12). Sleep 
disturbance are common adverse effects of cancer 
treatment (10). Sleep disturbance was found to be 
significantly different in CCS and BCS, in which it is being 
the best predictor of physical wellbeing in CCS (84.7% of 
influence). Table 3 showed that most CCS experienced 
moderate sleep disturbance (40.43%), compared to 
mostly mild sleep disturbance in BCS (67.24%). This 
possibly happened due to the adverse effects of cancer 
treatment, in which CCS undertook more complicated 
treatment than BCS as shown in Table 2. Sleep 
disruption is prevalent in patients with cancer and 
survivors, in which insomnia due to depression is 
prevalent, under-recognized, undermanaged, and 
understudied among patients with cancer, especially in 
those receiving chemotherapy (13). So, other than 
therapy, psychological distress in term of depression 
potentially causes sleep disturbance generally in people 
living with cancer. 
Appetite changes in cancer survivors happen due to 
taste and smell changes related to side effects of 
chemotherapy and socio-demographic factors, such as 
women in younger age, previous smell changes, less 
responsibility for cooking, concurrent medication, 
higher educational levels, and being on sick leave (14). 
Loss of olfactory/gustatory function can lead to 
malnutrition, weight loss, and possibly a prolonged 
morbidity of chemotherapy-induced adverse effects, 
decreased quality of life, poor compliance, and even 
decreased therapy response (15). Appetite change was 
found to be significantly different in CCS and BCS, in 
which it is being the best predictor of physical wellbeing 
in BCS (75.7% of influence). Table 3 showed that most 
CCS experienced severe appetite changes (38.30%) 
compared to mostly mild appetite changes in BCS 
(70.69%). This possibly happened due to the adverse 
effects of chemotherapy. From table 2 we could see 
that 87.23% CCS undertook chemotherapy as one of 
their main regiment, compared to 44.83% in BCS 
(totally). Chemotherapy has a significant but transient 
effect on olfactory and gustatory function, possibly 
causing reduced appetite, a low energy intake, and 
weight loss in breast cancer and other gynecologic 
malignancies in women (15).  
Constipation is a significant problem in patients 
taking morphine for alleviating cancer pain which affects 
a large proportion of cancer patients taking oral 
morphine, and this problem is generally inadequately 
treated (16). Table 3 showed that in both cases mild 
constipation occurred in most cases, but we could find 
more moderate and severe constipation in CCS even 
when more BCS participated in this study. This possibly 
happened due to the side effects of analgesic 
consumption, especially oral morphine or opioid. 
Constipation affects many patients receiving long-term 
opioid therapy for managing cancer pain (17). The data 
of opioid consumption in study respondents was not 
collected, but there were 6.67% respondents reported 
oral medicine consumption (unspecified).  
Nausea is a subjective phenomenon of an 
unpleasant, wavelike sensation experienced in the back 
of the throat and/or the epigastrium often culminating 
in vomiting (emesis). Vomiting is the forceful expulsion 
of the contents of the stomach, duodenum, or jejunum 
through the oral cavity. Vomiting can serve the function 
of emptying noxious chemicals from the gut, and nausea 
appears to play a role in a conditioned response to 
avoid ingestion of offending substances (18). Table 3 
showed that mild nausea-vomiting occurred mostly in 
both cases, but we could find more moderate and 
severe nausea-vomiting in CCS. This possibly happened 
due to the side effects of chemotherapy. 
Nausea and vomiting are two of the most frequent and 
troubling side effects patients experience during 
chemotherapy, interfering with compliance 
with cancer therapies and quality of life (19). From table 
2 we could see that 87.23% CCS undertook 
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chemotherapy as one of their main regiments, 
compared to 44.83% in BCS (totally). There are many 
factors inducing nausea-vomiting in cancer patients 
receiving opioids, such as age, body mass index, 
Karnofsky Performance Status, gender, usage of anti-
emetics, type of opioid, type of cancer and eight types 
of single nucleotide polymorphism (SNP) (20). The data 
of opioid consumption in study respondents was not 
collected, but there were 6.67% respondents reported 
oral medicine consumption (unspecified). 
The diagnosis of cancer appears to highlight 
concerns regarding menstrual changes and potential 
infertility, especially in younger women with breast 
cancer (21).  Table 3 showed that most CCS experienced 
moderate menstrual changes (51.06%), compared to 
most mild menstrual changes in BCS (53.45%). This 
possibly happened due to the side effects of 
chemotherapy. From table 2 we could see that 87.23% 
CCS undertook chemotherapy as one of their main 
regiment, compared to 44.83% in BCS (totally). History 
of hysterectomy was also important in determining 
menstrual changes in CCS, but this variable was 
unidentified in this study.  
Laparoscopic surgical techniques, including fertility-
sparing radical hysterectomy, have been proven to 
improve the quality of life in CCS (22). Premenopausal 
women undergoing chemotherapy are at risk for 
amenorrhea and impaired fertility. In young women 
with breast cancer, chemotherapy decreases mullerian 
inhibitory substance rapidly and dramatically. Ovarian 
reservation and endocrine function may be affected 
differently by chemotherapy among different patients 
(23). Similar study in CCS is not yet been demonstrated. 
Despite more serious cancer symptoms (especially pain 
and fatigue) occurred in CCS as shown in Table 3, more 
BCS perceived poor health status.  Perceived health 
status in cancer patient is influenced by education level, 
economic status, type of social insurance, time of cancer 
diagnosis, status of cancer, metastasis (24). Health 
status, especially in BCS, is also associated with 
occupation, pain, and fatigue (25). From Table 1 we 
could see that generally BCS were better educated than 
CCS, but they had similar economic status which was 
probably because most of them were housewives so 
that they could not contribute to the family’s income. 
Health status could improve over time along with the 
disease progression, in which survival time was 
independently associated with health status and quality 
of life in cancer survivors (26). Most respondents had 
survived from cancers for more than four years, as 
shown in Table 2 that most respondents were firstly 
diagnosed with cancer before 2014.  
Overall physical wellbeing was better in BCS, but 
most respondents reported sufficient wellbeing in both 
cases. Fatigue, appetite changes, pain, sleep 
disturbance, constipation, nausea-vomiting, menstrual 
changes, and health status (perceived) contribute to 
cancer survivors’ physical wellbeing in such a way so 
that it could be found better in BCS mostly due to 
relative absence of chemotherapy side effects because 
most respondents undertook surgery as their main 
regiment. Therefore early detection of cervical cancer 
should be promoted to younger women so that surgery 
could be performed as early as possible to avoid the 
various side effects of chemotherapy in the case of 
advanced stage cervical cancer.  
 
CONCLUSION 
 
More severe cancer symptoms were found in CCS, 
but poorer perceived health status was found in BCS. 
There were significant differences of fatigue, pain, sleep 
disturbance, appetite changes, constipation, nausea-
vomiting, menstrual changes, and perceived health 
status found between CCS and BCS. Sleep disturbance 
and appetite changes are the best predictor of physical 
wellbeing in CCS and BCS respectively. Overall, physical 
wellbeing was significantly different between CCS and 
BCS.   
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